Search

everythinglearnresearchcommunity

for

Search:↓

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

CGF therapy may help hair regrowth and improve scars in DLE patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Sponges made of soy protein and β-chitin with human cells from hair or fat can speed up healing of chronic wounds.

Exosomal miRNAs from stem cells can help improve skin health and delay aging.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Electrospun matrices help regenerate skin and hair follicles using PCL and collagen scaffolds.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Melatonin helps hair growth in women with hair loss.

To manage hair loss in adult women, find the cause and treat it accordingly.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The article explains how to tell apart and treat two common causes of hair loss in women.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

5% topical minoxidil can cause severe body hair growth, which disappears after stopping treatment.